$617 Million is the total value of Ikarian Capital, LLC's 114 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ICPT | New | INTERCEPT PHARMACEUTICALS INput | $93,547,000 | – | 754,900 | +100.0% | 15.16% | – |
| XBI | New | SPDR SERIES TRUSTput | $33,289,000 | – | 350,000 | +100.0% | 5.39% | – |
| GILD | New | GILEAD SCIENCES INCcall | $32,490,000 | – | 500,000 | +100.0% | 5.26% | – |
| ITCI | New | INTRA CELLULAR THERAPIES INCput | $31,706,000 | – | 924,100 | +100.0% | 5.14% | – |
| IBB | New | ISHARES TRput | $30,128,000 | – | 250,000 | +100.0% | 4.88% | – |
| ALLK | New | ALLAKOS INCcall | $15,143,000 | – | 158,800 | +100.0% | 2.45% | – |
| SRPT | New | SAREPTA THERAPEUTICS INCcall | $13,240,000 | – | 102,600 | +100.0% | 2.14% | – |
| MRTX | New | MIRATI THERAPEUTICS INCcall | $12,886,000 | – | 100,000 | +100.0% | 2.09% | – |
| BGNE | New | BEIGENE LTDput | $12,764,000 | – | 77,000 | +100.0% | 2.07% | – |
| GOSS | New | GOSSAMER BIO INCput | $12,052,000 | – | 771,100 | +100.0% | 1.95% | – |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO Lcall | $10,888,000 | – | 200,000 | +100.0% | 1.76% | – |
| GWPH | New | GW PHARMACEUTICALS PLCcall | $10,456,000 | – | 100,000 | +100.0% | 1.69% | – |
| ARQL | New | ARQULE INCcall | $9,934,000 | – | 497,700 | +100.0% | 1.61% | – |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $9,747,000 | – | 481,104 | +100.0% | 1.58% | – |
| ASND | New | ASCENDIS PHARMA A Scall | $9,655,000 | – | 69,400 | +100.0% | 1.56% | – |
| SAGE | New | SAGE THERAPEUTICS INC | $9,601,000 | – | 133,000 | +100.0% | 1.56% | – |
| IMMU | New | IMMUNOMEDICS INCcall | $9,484,000 | – | 448,200 | +100.0% | 1.54% | – |
| ITCI | New | INTRA CELLULAR THERAPIES INCcall | $9,164,000 | – | 267,100 | +100.0% | 1.48% | – |
| MDGL | New | MADRIGAL PHARMACEUTICALS INCput | $9,111,000 | – | 100,000 | +100.0% | 1.48% | – |
| APLS | New | APELLIS PHARMACEUTICALS INCput | $8,785,000 | – | 286,900 | +100.0% | 1.42% | – |
| ICPT | New | INTERCEPT PHARMACEUTICALS INcall | $8,042,000 | – | 64,900 | +100.0% | 1.30% | – |
| IMVT | New | IMMUNOVANT INC | $8,000,000 | – | 504,117 | +100.0% | 1.30% | – |
| GBT | New | GLOBAL BLOOD THERAPEUTICS INcall | $7,949,000 | – | 100,000 | +100.0% | 1.29% | – |
| ZGNX | New | ZOGENIX INCput | $7,726,000 | – | 148,200 | +100.0% | 1.25% | – |
| CRSP | New | CRISPR THERAPEUTICS AGput | $7,534,000 | – | 123,700 | +100.0% | 1.22% | – |
| APLS | New | APELLIS PHARMACEUTICALS INCcall | $7,358,000 | – | 240,300 | +100.0% | 1.19% | – |
| INCY | New | INCYTE CORPcall | $6,986,000 | – | 80,000 | +100.0% | 1.13% | – |
| ARQL | New | ARQULE INCput | $6,715,000 | – | 336,400 | +100.0% | 1.09% | – |
| ARWR | New | ARROWHEAD PHARMACEUTICALS INput | $6,343,000 | – | 100,000 | +100.0% | 1.03% | – |
| ARWR | New | ARROWHEAD PHARMACEUTICALS INcall | $6,343,000 | – | 100,000 | +100.0% | 1.03% | – |
| MRTX | New | MIRATI THERAPEUTICS INCput | $6,301,000 | – | 48,900 | +100.0% | 1.02% | – |
| DCPH | New | DECIPHERA PHARMACEUTICALS INcall | $6,224,000 | – | 100,000 | +100.0% | 1.01% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INCput | $5,989,000 | – | 140,000 | +100.0% | 0.97% | – |
| EIDX | New | EIDOS THERAPEUTICS INCcall | $5,739,000 | – | 100,000 | +100.0% | 0.93% | – |
| New | APTOSE BIOSCIENCES INC | $5,725,000 | – | 1,009,735 | +100.0% | 0.93% | – | |
| CHMA | New | CHIASMA INC | $5,472,000 | – | 1,103,297 | +100.0% | 0.89% | – |
| CLVS | New | CLOVIS ONCOLOGY INCcall | $5,355,000 | – | 513,700 | +100.0% | 0.87% | – |
| ARDX | New | ARDELYX INC | $4,844,000 | – | 645,436 | +100.0% | 0.78% | – |
| AMRN | New | AMARIN CORP PLCcall | $4,663,000 | – | 217,500 | +100.0% | 0.76% | – |
| ADVM | New | ADVERUM BIOTECHNOLOGIES INCcall | $4,503,000 | – | 390,900 | +100.0% | 0.73% | – |
| MYOK | New | MYOKARDIA INCput | $4,300,000 | – | 59,000 | +100.0% | 0.70% | – |
| OTIC | New | OTONOMY INC | $4,088,000 | – | 1,067,271 | +100.0% | 0.66% | – |
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $4,079,000 | – | 44,770 | +100.0% | 0.66% | – |
| KPTI | New | KARYOPHARM THERAPEUTICS INCput | $3,836,000 | – | 200,100 | +100.0% | 0.62% | – |
| KALV | New | KALVISTA PHARMACEUTICALS INC | $3,783,000 | – | 212,420 | +100.0% | 0.61% | – |
| KALA | New | KALA PHARMACEUTICALS INC | $3,776,000 | – | 1,023,431 | +100.0% | 0.61% | – |
| TGTX | New | TG THERAPEUTICS INC | $3,510,000 | – | 316,200 | +100.0% | 0.57% | – |
| ASMB | New | ASSEMBLY BIOSCIENCES INC | $3,222,000 | – | 157,468 | +100.0% | 0.52% | – |
| XENE | New | XENON PHARMACEUTICALS INC | $3,192,000 | – | 243,470 | +100.0% | 0.52% | – |
| ANAB | New | ANAPTYSBIO INCput | $3,141,000 | – | 193,300 | +100.0% | 0.51% | – |
| ASMB | New | ASSEMBLY BIOSCIENCES INCput | $3,069,000 | – | 150,000 | +100.0% | 0.50% | – |
| ARQL | New | ARQULE INC | $2,973,000 | – | 148,930 | +100.0% | 0.48% | – |
| AXSM | New | AXSOME THERAPEUTICS INCput | $2,884,000 | – | 27,900 | +100.0% | 0.47% | – |
| CERC | New | CERECOR INC | $2,802,000 | – | 519,800 | +100.0% | 0.45% | – |
| CVM | New | CEL SCI CORPput | $2,747,000 | – | 300,200 | +100.0% | 0.44% | – |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $2,723,000 | – | 311,253 | +100.0% | 0.44% | – |
| WVE | New | WAVE LIFE SCIENCES LTDput | $2,405,000 | – | 300,000 | +100.0% | 0.39% | – |
| AGIO | New | AGIOS PHARMACEUTICALS INCcall | $2,388,000 | – | 50,000 | +100.0% | 0.39% | – |
| ANAB | New | ANAPTYSBIO INC | $2,324,000 | – | 143,000 | +100.0% | 0.38% | – |
| BTAI | New | BIOXCEL THERAPEUTICS INC | $2,314,000 | – | 158,373 | +100.0% | 0.38% | – |
| OCUL | New | OCULAR THERAPEUTIX INC | $2,203,000 | – | 557,659 | +100.0% | 0.36% | – |
| ADRO | New | ADURO BIOTECH INC | $2,169,000 | – | 1,838,528 | +100.0% | 0.35% | – |
| RARE | New | ULTRAGENYX PHARMACEUTICAL IN | $2,136,000 | – | 50,000 | +100.0% | 0.35% | – |
| CCXI | New | CHEMOCENTRYX INC | $1,836,000 | – | 46,423 | +100.0% | 0.30% | – |
| MNKKQ | New | MALLINCKRODT PUB LTD CO | $1,787,000 | – | 512,000 | +100.0% | 0.29% | – |
| MGNX | New | MACROGENICS INCcall | $1,632,000 | – | 150,000 | +100.0% | 0.26% | – |
| CHRS | New | COHERUS BIOSCIENCES INCcall | $1,514,000 | – | 84,100 | +100.0% | 0.24% | – |
| INSM | New | INSMED INCcall | $1,461,000 | – | 61,200 | +100.0% | 0.24% | – |
| KALA | New | KALA PHARMACEUTICALS INCcall | $1,459,000 | – | 395,500 | +100.0% | 0.24% | – |
| OVID | New | OVID THERAPEUTICS INC | $1,453,000 | – | 350,000 | +100.0% | 0.24% | – |
| IFRX | New | INFLARX NV | $1,422,000 | – | 359,128 | +100.0% | 0.23% | – |
| SLDB | New | SOLID BIOSCIENCES INCcall | $1,360,000 | – | 305,600 | +100.0% | 0.22% | – |
| AIMT | New | AIMMUNE THERAPEUTICS INC | $1,339,000 | – | 40,000 | +100.0% | 0.22% | – |
| MBIO | New | MUSTANG BIO INC | $1,319,000 | – | 323,235 | +100.0% | 0.21% | – |
| VKTX | New | VIKING THERAPEUTICS INCput | $1,203,000 | – | 150,000 | +100.0% | 0.20% | – |
| VKTX | New | VIKING THERAPEUTICS INCcall | $1,203,000 | – | 150,000 | +100.0% | 0.20% | – |
| PBYI | New | PUMA BIOTECHNOLOGY INCcall | $1,161,000 | – | 132,700 | +100.0% | 0.19% | – |
| DTIL | New | PRECISION BIOSCIENCES INC | $1,111,000 | – | 80,000 | +100.0% | 0.18% | – |
| WVE | New | WAVE LIFE SCIENCES LTDcall | $1,077,000 | – | 134,400 | +100.0% | 0.18% | – |
| VKTX | New | VIKING THERAPEUTICS INC | $1,012,000 | – | 126,159 | +100.0% | 0.16% | – |
| AXGT | New | AXOVANT GENE THERAPIES LTD | $967,000 | – | 188,884 | +100.0% | 0.16% | – |
| AGTC | New | APPLIED GENETIC TECHNOL CORP | $908,000 | – | 200,884 | +100.0% | 0.15% | – |
| DBVT | New | DBV TECHNOLOGIES S Asponsored adr | $798,000 | – | 74,538 | +100.0% | 0.13% | – |
| NBIX | New | NEUROCRINE BIOSCIENCES INCcall | $774,000 | – | 7,200 | +100.0% | 0.12% | – |
| RIGL | New | RIGEL PHARMACEUTICALS INC | $749,000 | – | 350,000 | +100.0% | 0.12% | – |
| NERV | New | MINERVA NEUROSCIENCES INC | $711,000 | – | 100,000 | +100.0% | 0.12% | – |
| PGNX | New | PROGENICS PHARMACEUTICALS IN | $666,000 | – | 130,845 | +100.0% | 0.11% | – |
| BLU | New | BELLUS HEALTH INC NEW | $625,000 | – | 63,721 | +100.0% | 0.10% | – |
| OCUL | New | OCULAR THERAPEUTIX INCcall | $593,000 | – | 150,000 | +100.0% | 0.10% | – |
| MTEM | New | MOLECULAR TEMPLATES INC | $572,000 | – | 40,907 | +100.0% | 0.09% | – |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $552,000 | – | 78,326 | +100.0% | 0.09% | – |
| NERV | New | MINERVA NEUROSCIENCES INCcall | $530,000 | – | 74,500 | +100.0% | 0.09% | – |
| PRTA | New | PROTHENA CORP PLC | $472,000 | – | 29,832 | +100.0% | 0.08% | – |
| CMRX | New | CHIMERIX INC | $351,000 | – | 172,920 | +100.0% | 0.06% | – |
| DRNA | New | DICERNA PHARMACEUTICALS INCcall | $341,000 | – | 15,500 | +100.0% | 0.06% | – |
| OBSV | New | OBSEVA SA | $315,000 | – | 82,573 | +100.0% | 0.05% | – |
| CARA | New | CARA THERAPEUTICS INCcall | $285,000 | – | 17,700 | +100.0% | 0.05% | – |
| ZGNX | New | ZOGENIX INCcall | $240,000 | – | 4,600 | +100.0% | 0.04% | – |
| PRTO | New | PROTEON THERAPEUTICS INC | $138,000 | – | 336,373 | +100.0% | 0.02% | – |
| ARVN | New | ARVINAS INCcall | $127,000 | – | 3,100 | +100.0% | 0.02% | – |
| ARVN | New | ARVINAS INCput | $127,000 | – | 3,100 | +100.0% | 0.02% | – |
| SRRA | New | SIERRA ONCOLOGY INC | $132,000 | – | 386,399 | +100.0% | 0.02% | – |
| MGTA | New | MAGENTA THERAPEUTICS INC | $131,000 | – | 8,674 | +100.0% | 0.02% | – |
| MITO | New | STEALTH BIOTHERAPEUTICS CORPsponsored ads | $123,000 | – | 37,597 | +100.0% | 0.02% | – |
| MGNX | New | MACROGENICS INC | $109,000 | – | 10,030 | +100.0% | 0.02% | – |
| AEZS | New | AETERNA ZENTARIS INC | $107,000 | – | 117,443 | +100.0% | 0.02% | – |
| XFOR | New | X4 PHARMACEUTICALS INC | $107,000 | – | 10,000 | +100.0% | 0.02% | – |
| NVAX | New | NOVAVAX INC | $100,000 | – | 25,049 | +100.0% | 0.02% | – |
| PIRS | New | PIERIS PHARMACEUTICALS INCcall | $80,000 | – | 22,000 | +100.0% | 0.01% | – |
| CARA | New | CARA THERAPEUTICS INCput | $68,000 | – | 4,200 | +100.0% | 0.01% | – |
| SNSS | New | SUNESIS PHARMACEUTICALS INC | $38,000 | – | 111,445 | +100.0% | 0.01% | – |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $35,000 | – | 642 | +100.0% | 0.01% | – |
| ALPN | New | ALPINE IMMUNE SCIENCES INC | $18,000 | – | 4,739 | +100.0% | 0.00% | – |
| APLS | New | APELLIS PHARMACEUTICALS INC | $2,000 | – | 53 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-01-31
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| XENON PHARMACEUTICALS INC | 15 | Q2 2023 | 1.5% |
| OCULAR THERAPEUTIX INC | 15 | Q3 2023 | 1.4% |
| SAREPTA THERAPEUTICS INC | 14 | Q3 2023 | 6.4% |
| X4 PHARMACEUTICALS INC - PIPE | 14 | Q2 2023 | 1.4% |
| PROTARA THERAPEUTICS INC | 14 | Q3 2023 | 1.2% |
| SPDR SER TR | 13 | Q3 2023 | 9.0% |
| VAXCYTE INC | 13 | Q3 2023 | 2.9% |
| TRACON PHARMACEUTICALS INC | 13 | Q3 2023 | 1.4% |
| MILESTONE PHARMACEUTICALS IN | 13 | Q3 2023 | 1.7% |
| BELLUS HEALTH INC NEW | 13 | Q1 2023 | 1.8% |
View Ikarian Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. | February 14, 2023 | 460,416 | 1.3% |
| X4 Pharmaceuticals, Inc | February 14, 2023 | 349,133 | 0.3% |
| aTYR PHARMA INC | February 14, 2022 | 35,048 | 0.1% |
| Cyclacel Pharmaceuticals, Inc. | February 14, 2022 | 99,422 | 1.0% |
| KalVista Pharmaceuticals, Inc. | February 14, 2022 | 36,576 | 0.2% |
| Lyra Therapeutics, Inc. | February 14, 2022 | 394,536 | 3.0% |
| Odonate Therapeutics, Inc. | February 14, 2022 | 1,340,631 | 3.5% |
| Protara Therapeutics, Inc. | February 14, 2022 | 279,256 | 2.5% |
| Science 37 Holdings, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| scPharmaceuticals Inc. | February 14, 2022 | 901,362 | 3.3% |
View Ikarian Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-05 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
View Ikarian Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.